
Lupin Limited has informed the Exchange regarding a press release dated May 26, 2023, titled "Lupin Announces Health Canada Approval of Tiotropium Bromide Inhalation Powder for Treatment of COPD".
Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated May 26, 2023, titled "Lupin Announces Health Canada Approval of Tiotropium Bromide Inhalation Powder for Treatment of COPD".
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin